The clinical effect of dexmedetomidine preoperative nasal drip assisted in patients with strabismus correction under local anesthesia
10.16571/j.cnki.1008-8199.2020.08.008
- VernacularTitle: 右美托咪定术前滴鼻辅助用于局麻下斜视矫正术患者的临床效果
- Author:
Shao-ru WU
1
;
Ke PENG
1
;
Qing-cai CHEN
1
Author Information
1. Department of Anesthesiology, First Affiliated Hospital of Soochow University, Soochow 215006, Jiangsu,China
- Publication Type:Journal Article
- Keywords:
dexmedetomidine；itranasal；strabismus surgery;
sedation
- From:
Journal of Medical Postgraduates
2020;33(8):826-829
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo evaluate the effects of intranasal dexmedetomidine premedication on Sedation anxiety score, circulation index, drug dosage (atropine, sufentanil), and adverse reactions in patients undergoing strabismus surgery with local anesthesia. MethodsNinety patients undergoing strabismus surgery were enrolled and randomly divided into the dexmedetomidine group (n=45) and control group (n=45). 30min before the local anesthesia, dexmedetomidine was given intranasally with a dose of 2 μg/kg in the dexmedetomidine group, while the control group treated equal volume saline. The MAP and HR values before pre-dose (T0), 10 min (T1), 20 min (T2), and 30 min (T3) were recorded. The Ramsay score was calculated 30 minutes after administration. SAS scores were made 1 day before surgery and 1 day after surgery. Meanwhile, we measured the dosage of atropine, sufentanil, and the incidence of adverse reactions during surgery. ResultsThe HR and MAP of patients in the dexmedetomidine group were significantly lower than those in the control group at T2 and T3 (P<0.05). The SAS score of the dexmedetomidine group was significantly lower than that of the control group 1 day after the operation. There was no significant difference between the dexmedetomidine group and the control group in the dosage of atropine, the incidence of oculocardiac reflex (OCR), and respiratory depression. The dose of sufentanil in the dexmedetomidine group was lower than that of the control group. The incidence of nausea and vomiting in the control group was significantly higher than that of the dexmedetomidine group.Conclusion Dexmedetomidine (2 μg/kg) preoperative nasal drip has a good sedative effect without obvious adverse reactions and could be safely assisted in clinical anesthesia for patients undergoing local anesthesia correction surgery.
